Dr. Reddy's Share Price: Profit **86%** Gira! MobiKwik Ne Kamaya Profit, Kisne Maari Baazi?

STOCK-INVESTMENT-IDEAS
Whalesbook Logo
AuthorIshaan Verma|Published at:
Dr. Reddy's Share Price: Profit **86%** Gira! MobiKwik Ne Kamaya Profit, Kisne Maari Baazi?
Overview

Bhai log, Q4 FY26 ke results aa gaye hain aur picture ekdum mixed hai! Ek taraf pharma giant Dr. Reddy's ka profit **86%** crash ho gaya hai, aur dusri taraf fintech company MobiKwik ne finally profit dikhaya hai. Kuch companies ne toh kamaal kiya hai, par kuch pressure mein hain. Chal, dekhte hain pura scene.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

So, pharma world ki baat karein toh Dr. Reddy's Laboratories ne Q4 FY26 mein apne profits mein 86.2% ki girawat dekhi hai, jo ki ₹220.1 crore rah gaya. Iski wajah bani kuch one-time charges, jaise lenalidomide ke liye ₹453 crore ka adjustment, CAR-T assets par ₹228 crore ke impairment charges, aur VAT liability mein ₹114 crore ki provision. Revenue bhi 11.64% kam hokar ₹7,516.2 crore ho gaya. Yeh numbers dekh kar investors thoda pareshan hain.

Ab aao fintech waali MobiKwik Systems par. Yeh companies losses se nikal kar profit mein aa gayi hain! Q4 FY26 mein inhone ₹4.38 crore ka net profit kamaya, jabki pichhle saal isi quarter mein ₹56 crore ka loss tha. Cost control aur efficiency badhane se yeh ho paya. Revenue bhi 7.8% badhkar ₹289 crore ho gaya. Par interesting baat yeh hai ki profit mein aane ke baad bhi, inka stock 3.5% gir gaya, shayad sequential growth flat lagne ki wajah se.

Baki companies ki baat karein toh MTAR Technologies ne toh diwali manali hai. Revenue 67.2% badh kar ₹306.1 crore ho gaya aur profit 222.3% uddan bhar kar ₹44.3 crore tak pahunch gaya.

Inox India ne bhi 15% profit badhaya, ₹75.2 crore kamaya, aur revenue 25% chadha.

Berger Paints ka performance bhi zabardast raha, net profit 27.5% badh kar ₹335 crore ho gaya, margins sudharne aur volume growth 11.8% hone ke kaaran.

Tata Power ka consolidated profit 8.3% badhkar ₹1,415.52 crore ho gaya, jismein renewable energy ka role bada hai.

Lekin, Dixon Technologies ko thoda pressure face karna pada. Profit 36% gir kar ₹256 crore rah gaya, revenue bas 2% badha. Iska reason hai margin compression aur PLI scheme ka khatm hona.

Gaming sector se Nazara Technologies ne toh kamaal kar diya, profit threefold badh kar ₹55.7 crore ho gaya, bhale hi revenue thoda kam hua ho, 'other income' ki wajah se sab theek ho gaya.

Aur Texmaco Rail & Engineering ka profit 62% badh kar ₹58 crore ho gaya, unko ek $430 million ka bada export order bhi mila hai, aur ₹200 crore ka investment bhi kiya hai defence subsidiary mein.

Analysts ab Dr. Reddy's ke profit ko lekar thoda sawaal utha rahe hain ki kya woh future mein bhi yeh performance maintain kar paayenge. Margin 5.09% tak simat gaya hai, jo pehle 23.49% tha. One-time items ko chhod kar core business mein bhi challenges dikh rahi hain.

Dixon Technologies ke liye bhi PLI scheme ka end aur raw material costs ka pressure ek chinta ka vishay hai. MobiKwik ke liye, profit mein aana achha hai, par stock gira hai kyunki investors ab aur strong revenue growth dekhna chahte hain, sirf cost cutting se kaam nahi chalega.

Toh overall, Q4 FY26 earnings season mixed signals de raha hai. Companies jo consistently revenue grow kar rahi hain, costs manage kar rahi hain aur margins badha rahi hain, jaise Berger Paints aur MTAR Technologies, woh investors ka confidence jeet rahi hain. Wahi, Dr. Reddy's aur Dixon Technologies jaise companies jinko operational ya structural challenges face karni pad rahi hain, un par ab zyada scrutiny rahegi.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.